OZIOMA NWOSU: Open Payments
NPI 1457726135 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$212 in 8 payments from 4 companies in 2025. Trend: 2023 $432 · 2024 $273 · 2025 $212
Food & beverage: $212
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $114 |
| Sage Therapeutics, LLC | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
Products named: CAPLYTA, ZURZUVAE, ABILIFY ASIMTUFII, Qelbree.
Industry payments across NV — which companies pay providers there.
